Fresenius Medical Care Q2 2024 Results Announced
Ticker: FMCQF · Form: 6-K · Filed: Jul 30, 2024 · CIK: 1333141
| Field | Detail |
|---|---|
| Company | Fresenius Medical Care Ag (FMCQF) |
| Form Type | 6-K |
| Filed Date | Jul 30, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, financial-results
Related Tickers: FME
TL;DR
FME released Q2 2024 results on July 30th, including non-GAAP figures.
AI Summary
Fresenius Medical Care AG announced its second quarter results for the period ending June 30, 2024, on July 30, 2024. The company issued a press release detailing these results, which include non-GAAP financial measures. The full financial figures were provided as an exhibit.
Why It Matters
This filing provides investors with the latest financial performance data for Fresenius Medical Care, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine earnings announcement and does not contain significant new risks.
Key Players & Entities
- Fresenius Medical Care AG (company) — Registrant
- June 30, 2024 (date) — End of Q2 reporting period
- July 30, 2024 (date) — Date of press release and filing
FAQ
What period do the announced results cover?
The results announced cover the second quarter for the period ending June 30, 2024.
When did Fresenius Medical Care announce these results?
Fresenius Medical Care announced its second quarter results on July 30, 2024.
What form is this report filed under?
This report is filed as a Form 6-K.
Are the financial figures presented on a GAAP or non-GAAP basis?
The attached Press Release contains non-GAAP financial measures.
Where can the corresponding financial figures be found?
The corresponding financial figures were provided as Exhibit 99.2.
Filing Stats: 568 words · 2 min read · ~2 pages · Grade level 15.7 · Accepted 2024-07-30 06:00:34
Filing Documents
- tm2418955d3_6k.htm (6-K) — 14KB
- tm2418955d3_ex99-1.htm (EX-99.1) — 72KB
- tm2418955d3_ex99-2.htm (EX-99.2) — 966KB
- tm2418955d3_ex99-1img001.jpg (GRAPHIC) — 5KB
- tm2418955d3_ex99-1img004.jpg (GRAPHIC) — 90KB
- tm2418955d3_ex99-1img005.jpg (GRAPHIC) — 87KB
- tm2418955d3_ex99-1img006.jpg (GRAPHIC) — 463KB
- tm248955d3_ex99-2img01.jpg (GRAPHIC) — 3KB
- 0001104659-24-083673.txt ( ) — 1946KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. DATE: July 30, 2024 Fresenius Medical Care AG By: /s/ Helen Giza Name: Helen Giza Title: Chief Executive Officer and Chair of the Management Board By: /s/ Martin Fischer Name: Martin Fischer Title: Chief Financial Officer and member of the Management Board